Most recent by Julie R. Gralow, MD, FACP, FASCO
Black patients with metastatic breast cancer often not informed of clinical trials
Most Black patients with cancer reported a somewhat or very high likelihood of considering clinical trial participation, yet many had not been informed of the opportunity to enroll onto a clinical trial, study results showed.
Racial disparities in cancer survival shrink with increased public welfare spending
Increased state spending on social services such as Medicaid correlated with improved 5-year overall survival among Black adults with cancer, according to study results scheduled for presentation at ASCO Annual Meeting.
Two nivolumab regimens outperform chemotherapy alone in advanced esophageal cancer
The addition of nivolumab to chemotherapy or ipilimumab significantly improved OS compared with chemotherapy alone among patients with previously untreated advanced esophageal squamous cell carcinoma, according to phase 3 study findings.
Dual checkpoint blockade improves PFS as first-line treatment of advanced melanoma
The addition of relatlimab to nivolumab conferred a significant PFS benefit among treatment-naive patients with advanced melanoma, according to results of the phase 2/phase 3 RELATIVITY-047 study presented at the virtual ASCO Annual Meeting.
Finding Your Own Way with Julie Gralow, MD
Julie Gralow, MD, is a well-respected and internationally renowned breast oncologist. In this episode, Gralow discusses her journey in oncology, the ASCO Global Oncology Task Force and the importance of finding your own way in medicine.